Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Legal & IP

Set Alert for Legal & IP

Latest From Legal Issues

FTC Scrutiny Of Profit Seeking In Drug Supply Chain In Fact-Finding Mode

Agency hears from experts on whether PBMs and group purchasing organizations operate under misaligned incentives.

Pricing Debate Legal Issues

Pharma Faces More Probes On Generic Price Hikes in UK

As Concordia finds itself in the dock again, this time over its pricing of the essential thyroid treatment liothyronine, the UK's Competition and Markets Authority has recently opened four new investigations into "suspected abuse of dominance" concerning generics.

Legal Issues Pricing Strategies

What Is Inter Partes Review?

A description of the patent challenge proceeding and how it differs from district court litigation.

Intellectual Property Legal Issues

How Comprehensive Do IPR Decisions Have To Be?

Supreme Court to consider whether Patent Trial and Appeal Board must address all patent claims challenged in an inter partes review petition.

BioPharmaceutical Policy

Will Inter Partes Review Go Away? Supreme Court Weighs Fate

Biopharma and generic industries stand on opposing sides in case that could eliminate the patent challenge proceeding. Interactive timeline covers IPR's five-year history leading to oral arguments Nov. 27.

Legal Issues Intellectual Property

Holes In Road To Unified Patent Court Could Derail The Project – And Hit Plans For EU SPC

Negotiations over Brexit and a legal challenge lodged in Germany are holding up progress with establishing the proposed Unified Patent Court, and could also affect plans for an EU-wide supplementary protection certificate, according to legal experts.

Intellectual Property Brexit
See All
UsernamePublicRestriction

Register